Sanjivani Paranteral Ltd, a pharmaceutical powerhouse based in Mumbai, has announced remarkable financial results for Q2 of the fiscal year 2025, showcasing significant growth across revenue and profitability metrics. With a year-on-year revenue increase of 29.5%, the company has reinforced its leadership in manufacturing parenteral and oral solid products, particularly in therapeutic areas such as […]
Sanjivani Paranteral Ltd (BSE: 531569), a renowned pharmaceutical company based in Mumbai with manufacturing facilities in Navi Mumbai and Dehradun, has announced impressive financial results for the fourth quarter of FY24, showcasing significant growth and strategic expansions. Financial Performance Highlights: In Q4 FY24, Sanjivani Paranteral reported a substantial increase in revenue, which grew 58.38% year-over-year […]
